SAN DIEGO – Children with hospital-acquired VTE tended to be more medically complex, a single-center study showed.
SAN DIEGO – Bleeding episodes and need for treatment were more frequent among boys with types 1 and 2 von Willebrand disease.
The U.S. hemophilia drug market, which serves about 20,000 patients, is worth $4.6 billion a year.
“There aren’t a lot of options available to Medicaid programs in terms of controlling costs, because we don’t set the initial costs”
The estimated mortality is highest in Maine and West Virginia, lowest in Utah.
In patients with stable atherosclerotic vascular disease, treatment with low-dose rivaroxaban plus aspirin halved the incidence of ischemic...
In vitro studies show strong results for spray-dried plasma, which could have implications on the battlefield.
Dr. Cynthia Dunbar, of the NIH, talks about the “critical mass of successes” in hematology and what is coming in the future.
Early research sheds light on sex differences in thrombosis risk.
From the Journals
Diagnosis appears to be the time with greatest risk.
Eltrombopag, from Novartis, will get expedited review for first-line treatment of severe aplastic anemia. It is already approved as a second-line...